Treatment of Torulopsis glabrata vaginitis: retrospective review of boric acid therapy.
about
Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicansMaking inroads into improving treatment of bacterial vaginosis - striving for long-term cureVulvovaginitis due to Candida glabrata. An emerging problem.Vulvovaginitis in healthy women.Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases.Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.Infectious vaginitis. An accurate diagnosis is essential and attainable.Terconazole cream for non-Candida albicans fungal vaginitis: results of a retrospective analysisAntifungal resistance in yeast vaginitis.Vaginal candidosis: epidemiological and etiological factors.Recurrent vaginal candidiasis changes in etiopathogenical patterns.The epidemiology, pathogenesis, and diagnosis of vulvovaginal candidosis: a mycological perspective.Fluconazole susceptibility of vaginal isolates obtained from women with complicated Candida vaginitis: clinical implications.Multilocus sequence typing of Candida glabrata reveals geographically enriched clades.What to do with the patient with recurrent vulvovaginal candidiasis.Candida lusitaniae as an unusual cause of recurrent vaginitis and its successful treatment with intravaginal boric acidBoric acid vaginal suppositories: a brief review.The diagnosis and treatment of infectious vaginitis.Effect of pH on in vitro susceptibility of Candida glabrata and Candida albicans to 11 antifungal agents and implications for clinical use.BASIC study: is intravaginal boric acid non-inferior to metronidazole in symptomatic bacterial vaginosis? Study protocol for a randomized controlled trialLocal treatment of vulvovaginal candidosis : general and practical considerations.Vulvovaginal candidosis: contemporary challenges and the future of prophylactic and therapeutic approaches.Therapeutic efficacy of posaconazole against Candida glabrata in a murine model of vaginitis.Vaginitis due to Candida krusei: epidemiology, clinical aspects, and therapy.Trends in prescribing for vulvovaginal candidiasis in the United States.Vulvovaginal candidiasis in children and adolescents with type 1 diabetes mellitus.Antimicrobial activity of AmBisome and non-liposomal amphotericin B following uptake of Candida glabrata by murine epidermal Langerhans cells.Vulvovaginal candidiasis is associated with the production of germ tubes by Candida albicans.Candida vaginitis during contraceptive use: the influence of methods, antifungal susceptibility and virulence patterns.Prevalence, susceptibility profile and proteinase production of yeasts causing vulvovaginitis in Turkish women.Biofilms and beyond: expanding echinocandin utility.NmeA, a novel efflux transporter specific for nucleobases and nucleosides, contributes to metal resistance in Aspergillus nidulans.Boric Acid and Commercial Organoboron Products as Inhibitors of Drug-Resistant Candida albicans.Boric acid susceptibility testing of non-C. albicans Candida and Saccharomyces cerevisiae: comparison of three methods.Boric acid for refractory Candida glabrata vaginitis.Yeast vaginitis during pregnancy: susceptibility testing of 13 antifungal drugs and boric acid and the detection of four virulence factors.Antimicrobial Resistance in Vulvovaginitis.
P2860
Q24550731-D8EBC0C6-58A5-4535-BB79-AE89B6110D87Q26798310-83C9B295-6F40-46A8-8E1D-C37D079AD688Q33543369-CA492FD1-AB9D-47AD-A712-B5874BEB054FQ33724650-832ABF90-0888-487A-8022-5A4F702673E1Q33859133-82BACCF2-C6C2-46D1-9F0B-EA3D5E1CCB74Q33894467-460312BB-2C83-499A-BFA5-B4D42E7C589EQ33897706-C2DC2BC6-1A66-4ABA-B339-9B005644514EQ33935571-E7094FB0-B404-4544-BAAC-573748E2543BQ33977460-BA81653D-F132-4255-9F4A-0DC5B0B85B3FQ34105393-AE5AEE1D-7717-48F4-8D97-329E583900DCQ34105397-836D7BC6-0E16-4482-BC67-4C40185C98C3Q34186380-20194979-35EC-4309-886C-EA7564C3675EQ34720549-AAD309CA-FF57-4069-9DD8-AB4F0735459EQ34953693-5C1718CE-B008-4C6A-9C8A-A8F56667EDEEQ35562545-37A09EFF-802A-404B-B820-8197C75D7E25Q35614942-0313AB91-9302-4D92-BA20-E4019BFB2416Q35615488-28196899-6CD2-483E-ACBE-DFD7E227ECB3Q35646054-86190406-5622-454B-8985-EC12169ADC6DQ35806236-717A6216-027D-4DA9-A38E-F36EB773568BQ35888829-23D7DA97-7F33-4BE9-AD2E-FC90904B3448Q37253003-641D0A17-3138-45D0-A25D-C28EAE8A8CBDQ38696236-D26B770A-60B9-49D3-963A-1ED55B6F4A87Q43265503-E5940269-10BA-4A32-9A29-CDCA8AA14387Q44183252-64A3BB19-1E0D-4A32-A186-927D1C80461BQ45073888-498674FF-8EDD-46D8-BBB4-3BBEA8233A5EQ45167478-A3DE5F97-9D1E-4C6D-99E9-FE17D9B0651DQ46487007-ECB091D7-2344-4D34-81D8-8AA92F53FC9DQ46571049-97B31DE8-64FD-482C-8376-C0B8D34B2194Q46972633-0DF7EFEF-3C0A-4DB6-8F5E-7AF5683E0879Q46977486-FCF02222-B978-40F1-B39C-FC1C2C1BE6E2Q47205366-732216BA-C736-4748-87CB-9457E6F46A24Q48137767-C29CA31D-A711-4BC0-A488-FFED0D1E8C15Q48218743-903DF129-82EE-4BD7-9F4F-9EF11EA3E496Q52598092-238F1714-EBF6-45F0-A754-34AE31639C33Q52672661-F2F95ACF-A17A-4CF1-8814-08A58635B61DQ52734706-5CDF32BA-4465-4AE0-9C3A-C3735BDCD70AQ53987130-E59FEF8D-B37F-4D8C-9C0F-3673AB485740
P2860
Treatment of Torulopsis glabrata vaginitis: retrospective review of boric acid therapy.
description
1997 nî lūn-bûn
@nan
1997 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Treatment of Torulopsis glabrata vaginitis: retrospective review of boric acid therapy.
@ast
Treatment of Torulopsis glabrata vaginitis: retrospective review of boric acid therapy.
@en
Treatment of Torulopsis glabrata vaginitis: retrospective review of boric acid therapy.
@nl
type
label
Treatment of Torulopsis glabrata vaginitis: retrospective review of boric acid therapy.
@ast
Treatment of Torulopsis glabrata vaginitis: retrospective review of boric acid therapy.
@en
Treatment of Torulopsis glabrata vaginitis: retrospective review of boric acid therapy.
@nl
prefLabel
Treatment of Torulopsis glabrata vaginitis: retrospective review of boric acid therapy.
@ast
Treatment of Torulopsis glabrata vaginitis: retrospective review of boric acid therapy.
@en
Treatment of Torulopsis glabrata vaginitis: retrospective review of boric acid therapy.
@nl
P356
P1476
Treatment of Torulopsis glabrata vaginitis: retrospective review of boric acid therapy.
@en
P2093
P304
P356
10.1093/CLIND/24.4.649
P407
P577
1997-04-01T00:00:00Z